These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3923951)

  • 1. Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.
    Hanly JG; Bresnihan B
    Ann Rheum Dis; 1985 May; 44(5):299-301. PubMed ID: 3923951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the response of the leukopenia of rheumatoid arthritis to gold salt therapy.
    Mastaglia GL; Owen ET
    J Rheumatol; 1981; 8(4):658-60. PubMed ID: 6795350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chrysotherapy on circulating lymphocyte numbers and subsets.
    Smith MD; Smith A; Fehr M; Ahern MJ; Roberts-Thomson PJ
    Ann Rheum Dis; 1988 Jan; 47(1):15-7. PubMed ID: 3125797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination.
    Lewis P; Hazleman BL; Park JR; Bulgen DY; Franks D; Hurd C; Brown DL
    Clin Rheumatol; 1982 Sep; 1(3):168-75. PubMed ID: 6821381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy.
    Walters MT; Smith JL; Moore K; Evans PR; Cawley MI
    Ann Rheum Dis; 1987 Jan; 46(1):7-16. PubMed ID: 3101623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.
    Pritchard MH; Nuki G
    Ann Rheum Dis; 1978 Dec; 37(6):493-503. PubMed ID: 107867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis.
    Pedersen BK; Abom B
    Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of rheumatoid arthritis with leukopenia to gold salts.
    Gowans JD; Salami M
    N Engl J Med; 1973 May; 288(19):1007-8. PubMed ID: 4633144
    [No Abstract]   [Full Text] [Related]  

  • 10. beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.
    Latt D; Weiss JB; Jayson MI
    Ann Rheum Dis; 1981 Apr; 40(2):157-60. PubMed ID: 6164344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in immune function in patients with rheumatoid arthritis following treatment with sodium aurothiomalate.
    Highton J; Panayi GS; Shepherd P; Griffin J; Gibson T
    Ann Rheum Dis; 1981 Jun; 40(3):254-62. PubMed ID: 6787996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in peripheral blood lymphocyte response to concanavalin A and pokeweed mitogen during gold treatment of rheumatoid arthritis.
    Highton J; Panayi GS; Griffin J
    Agents Actions; 1980 Dec; 10(6):507-8. PubMed ID: 6791479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis.
    Hassan J; Hanly J; Bresnihan B; Feighery C; Whelan CA
    Clin Exp Immunol; 1986 Mar; 63(3):614-20. PubMed ID: 3086003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of anti-rheumatic drugs on human lymphocytes in vitro.
    Yoshino S; Ishiyama I
    Z Rheumatol; 1977; 36(1-2):28-35. PubMed ID: 402750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
    Heath MJ
    Ann Rheum Dis; 1988 Jan; 47(1):18-21. PubMed ID: 3125798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
    Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR
    Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line drug treatment in rheumatoid arthritis associated with depressed autologous mixed lymphocyte reaction.
    Panayi GS; Mills MM
    Rheumatol Int; 1986; 6(1):25-9. PubMed ID: 2947308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on pyrimidine biosynthesis in the granulocytes of patients receiving gold therapy for rheumatoid arthritis.
    Westwick WJ; Allsop J; Gumpel JM; Watts RW
    Q J Med; 1974 Apr; 43(170):231-43. PubMed ID: 4369231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.